The fact that these authors did not observe VE-cadherin expression at the tumor cell endothelial cell contacts might be explained by the different cell lines used: our experiments were designed to specifically address the behavior of VE-cadherin positive breast cancer cells. The gene discussed is CDH5; the disease is breast cancer.